John Hoeven sold BMY

January 20, 2017 · STOCK Act disclosure

Senator John Hoeven (Republican-ND) sold Bristol-Myers Squibb Company, a stock transaction, valued at $50,001 - $100,000. The trade took place on January 20, 2017 and was disclosed on January 25, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.

Type

Sell

Amount

$50,001 - $100,000

Transaction date

January 20, 2017

Disclosed

January 25, 2017

MemberJohn Hoeven

ChamberSenate

Party / StateRepublican · ND

AssetBristol-Myers Squibb Company (BMY)

Security typeStock

OwnerSelf

Amount range$50,001 - $100,000

Transaction dateJanuary 20, 2017

Filing dateJanuary 25, 2017

AmendmentNo

Asset description

Bristol-Myers Squibb Company

View the original STOCK Act disclosure